Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,114.30 +74.27 (+0.11%) CMC Crypto 200
1,404.29 -13.59 (-0.96%)
Capricor Therapeutics, Inc. (CAPR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 164.47M |
| Enterprise value | 126.57M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.40 |
| Price/book (mrq) | 8.92 |
| Enterprise value/revenue | 4.67 |
| Enterprise value/EBITDA | -3.14 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.97 |
| 52-week change 3 | 6.60% |
| S&P500 52-week change 3 | 23.76% |
| 52-week high 3 | 8.22 |
| 52-week low 3 | 2.68 |
| 50-day moving average 3 | 5.62 |
| 200-day moving average 3 | 4.70 |
Share statistics
| Avg vol (3-month) 3 | 377.63k |
| Avg vol (10-day) 3 | 355.11k |
| Shares outstanding 5 | 31.81M |
| Implied shares outstanding 6 | 31.81M |
| Float 8 | 26.39M |
| % held by insiders 1 | 8.26% |
| % held by institutions 1 | 23.93% |
| Shares short (15 May 2024) 4 | 4.21M |
| Short ratio (15 May 2024) 4 | 11.13 |
| Short % of float (15 May 2024) 4 | 15.93% |
| Short % of shares outstanding (15 May 2024) 4 | 13.24% |
| Shares short (prior month 15 Apr 2024) 4 | 3.59M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 05 Jun 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 05 Jun 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -89.72% |
| Operating margin (ttm) | -209.21% |
Management effectiveness
| Return on assets (ttm) | -31.65% |
| Return on equity (ttm) | -197.34% |
Income statement
| Revenue (ttm) | 27.1M |
| Revenue per share (ttm) | 0.96 |
| Quarterly revenue growth (yoy) | 64.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -24.99M |
| Net income avi to common (ttm) | -24.31M |
| Diluted EPS (ttm) | -0.83 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 39.92M |
| Total cash per share (mrq) | 1.25 |
| Total debt (mrq) | 2.02M |
| Total debt/equity (mrq) | 10.96% |
| Current ratio (mrq) | 1.57 |
| Book value per share (mrq) | 0.58 |
Cash flow statement
| Operating cash flow (ttm) | -31.08M |
| Levered free cash flow (ttm) | -19.87M |
© 2024 Yahoo. All rights reserved.